We’re on a mission to enable effective therapies to people faster.
A novel approach to research
For the past two decades clinical research has been hindered by outdated processes and technologies leaving millions without treatments.
After struggling to access patients in her own research in rare skin diseases, Dr. Michelle Longmire set out to solve this long-standing challenge in research.
Drawing inspiration from innovation and technological advancements in other industries, Longmire rallied stakeholders, partners, and developers to launch our company, Medable, with the shared vision of radically increasing the number of effective therapies to people each year.
Committed to science. Powered by innovation.
In order to achieve this vision, we needed to amplify the quality, reach, velocity, and cost of research.
Driven by the belief that clinical research can and should be better, we've assembled world-class scientific and product teams to continuously drive evidence-based improvements to the trial experience for all.
The relentless pursuit of progress, together.
Human connection is at the heart of everything we do. We prioritize the personal experience of patients, caregivers, knowing that their knowledge and feedback are essential to improving clinical research. In close partnership with with our network of sites, we continuously improve our platform, because we know that when they win, we all win. By designing products that are more accessible and user-friendly, we can bring life-change treatments to those who need them faster.
Together, with our clients and partners, we continue to work toward our mission and drive clinical research forward for the betterment of all.
Accolades
The latest from Medable
Why cloud-based eCOA software is becoming the industry standard
The landscape of clinical trials is evolving rapidly, and at the forefront of this transformation is eCOA (electronic Clinical Outcome Assessment) software. This technology is streamlining data collection, enhancing patient compliance, and ensuring regulatory adherence like never before.
Medable Studio Showcase
More than an eCOA builder, Medable Studio’s simple point and click interface brings total control and transparency to the study launch process.
Demo On Demand: eCOA+, patient & site experiences, and pulse oximeter sensor
VP of Solution Consulting, Jess Dolphi, showcases a few of the platform’s features, including site experience, patient experience, data and oversight dashboards, and a demonstration of connecting a pulse oximeter sensor for remote data capture.
Medable Launches Partner Program for Faster Clinical Trial Startup, Greater Control, and Transparent Pricing
Medable unveils its new Partner Program, designed to empower contract research organizations (CROs) and other partners with generative AI-driven, self-service eCOA build capabilities for digitally enabled clinical trials.
Medable Introduces Long-Term Follow-Up Model for Cell & Gene Therapy (CGT) Trials to Reduce Costs and Improve Patient Access
Medable unveils its digital-first, Long-Term Follow-Up (LTFU) model for cell and gene therapy (CGT) trials. Medable’s platform reduces the burden on patients and sites involved in complex CGT trials and enhances scientific integrity with sustainable data capture across the FDA-required 15-year follow-up period for certain CGTs, including those using genome-editing techniques.
New Data Reveals DCT Components Linked to Improvements in Clinical Trial Access Among Underrepresented Communities
Medable's groundbreaking study with the Tufts PACT Consortium highlights the transformative impact of decentralized clinical trials (DCTs) on diversity.